“Are employers really stepping up to take care of their health providers? I think [that] is something that also probably needs to change.”
Here's a roundup of the latest coronavirus-related news.
Julie Ann Justo, PharmD, infectious diseases clinical pharmacist and assistant professor at the University of South Carolina College of Pharmacy, discusses the treatment potential for remdesivir for SARS-CoV-2, as well as distribution strategies for the drug.
A recent analysis showed a surge in prescription fills for hydroxychloroquine/chloroquine, likely due to off-label prescribing for coronavirus disease 2019.
“Testing is coming, but getting there is a step-by-step process, and you need to work out the logistics.”
Carla Cox, PhD, registered dietician and certified diabetes educator, discusses key information about COVID-19 that individuals with diabetes should know.
Pharmacies and pharmacists can help the rapid deployment of COVID-19 vaccines when available, NACDS said.
The SIMPLE trial found the 5-day remdesivir treatment arm to be 65% more likely to have clinical improvement compared with standard of care alone in patients with moderate COVID-19.
An analysis found that US patients with COVID-19 are experiencing longer hospital stays and higher rates of ICU admissions than patients in China.
Here's this week's roundup of the latest coronavirus-related news.